It is normally bound to intracellular components, even though a secondary messenger is a plasma membrane receptor.

This forms a tough barrier between the intracellular components and the extracellular environment, which has to be penetrated.

However, during molecular studies in the laboratory, it became apparent that celecoxib could interact with other intracellular components besides its most famous target, cyclooxygenase 2 (COX-2).

The intracellular components of the RBCs are released into the circulating blood and into tissues, leading to some of the characteristic symptoms of this condition.

Contamination of isolated cell membranes with intracellular components would therefore probably result in the detection of pre-Β chains in the normal colonic mucosa.

This prevents exposure of tissue to toxic enzymes, oxidants and other intracellular components such as proteases and caspases.

Because these molecules physically disrupt the bacterial membrane rather than target an intracellular component, bacteria are less able to develop resistance.

Significant adipocyte expansion is believed to interrupt the interplay of transcriptional factors and other intracellular components yielding pathological consequences.

The cell membrane or plasma membrane surrounds the cytoplasm of living cells, physically separating the intracellular components from the extracellular environment.

The two most common targets for advancements are the growth medium (Open pond vs. Bioreactor) and methods to remove the intracellular components of the algae.